The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 737.00
Bid: 738.00
Ask: 743.00
Change: -12.00 (-1.60%)
Spread: 5.00 (0.678%)
Open: 718.00
High: 750.00
Low: 718.00
Prev. Close: 749.00
DSCV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Disposal of Supply Chain Business

15 May 2014 07:00

RNS Number : 1641H
Acal PLC
15 May 2014
 



15 May 2014

 

 

 

 

 

Acal plc

 

Proposed disposal of the Supply Chain Division's

Enterprise Business

 

Acal plc (LSE: ACL, "Acal", the "Group" or the "Company"), a leading European specialist electronics supplier, is pleased to announce the proposed disposal of the remaining business contained within its Supply Chain Division (the "Disposal"). The Group has agreed to sell its UK based IT spares and support services business (the "Enterprise Business") to a company in which the management team of that business is participating. The Disposal is subject to shareholder approval. For the year ended 31 March 2013, the Enterprise Business had revenues of £6.1m and generated profit before tax of £1.2m.

 

The Disposal reflects Acal's continued strategy of building a specialist electronics supplier to the industrial and medical sectors and completes its programme of non core business disposals, following on from the prior disposals of its UK parts Business in January 2013 and its European Parts Business in November 2013.

 

The total consideration for the Disposal, if approved, will be £6.0m, comprising initial consideration of £5.7m payable on completion and deferred consideration of £0.3m payable by 31 December 2014. Including transaction and related costs, the Disposal is expected to result in a profit on disposal (excluding goodwill) of £2.4m and a loss on disposal of £3.3m (including goodwill). Sale proceeds from the Disposal will be retained for working capital purposes, for future investment within the Group or as consideration for future acquisitions by the Group.

 

With the Enterprise Business being the last remaining company in the Supply Chain Division, the Division will now be treated as a discontinued business for accounting purposes in the forthcoming Group financial statements for the year ended 31 March 2014. Accordingly, the Division's results will be shown separately in the Group's income statement. The Group's balance sheet, statement of cash flows and underlying notes to the financial statements will also be amended accordingly. Prior year comparatives will be similarly restated to enable shareholders to understand the underlying trend information.

 

As a result of the requirement to effect these changes, the Company now expects to announce its final results for the year ended 31 March 2014 on 5 June 2014. There has been no change in trading performance or financial position since the Company's trading update on 10 April 2014.

 

Nick Jefferies, Group Chief Executive of Acal plc said:

 

"The proposed sale of the Enterprise business completes our disposal of the Supply Chain division. We wish the Enterprise management every success in the future.

 

The sale proceeds will be invested in furthering our strategy of building a specialist electronics business through funding our well developed pipeline of acquisition opportunities or otherwise invested in underlying organic growth."

For further information please contact:

Acal plc 01483 544 500

Nick Jefferies - Group Chief Executive

Simon Gibbins - Group Finance Director

 

Oriel Securities Limited (Sponsor) 0207 710 7600

David Arch

Stewart Wallace

 

Instinctif Partners 0207 457 2020

Mark Garraway

Helen Tarbet

 

 

The disposal of the Enterprise Business

 

The Enterprise Business, which is based in the UK, provides a comprehensive parts support service to both the OEM and maintenance markets. It primarily supports end of service life mid-range and mainframe enterprise systems, such as computer servers and data centres. Although profitable, it is capital intensive and considered non-core to the Group.

 

This disposal will involve the sale of Acal's UK subsidiary, Acal Enterprise Solutions Limited ("AES Limited"), to Agilitas Holdings Limited, a new company, owned by NVM Private Equity and the current management team of AES Limited (the "Enterprise Management Team"). No material transitional arrangements are expected to be required from the Continuing Group as a result of the Disposal.

 

In addition to the purchase price of £6.0 million, additional consideration will also be payable if AES Limited or its business is sold within 12 months following completion, equal to 20 per cent. of any sale proceeds over £8.5 million.

 

 

Summary financials relating to the Enterprise Business

Year ended 31 Mar 12

Year ended 31 Mar 13

6 months ended

30 Sept 13

 

Revenue

 

£5.6m

£6.1m

£3.1m

 

Contribution to profit before tax

£1.1m

£1.2m

£0.6m

 

Contribution to underlying operating profit*

£1.2m

£1.3m

£0.6m

 

Gross Assets

£10.0m

£10.1m

 

Of which Goodwill

£5.7m

£5.7m

 

 

* Contribution to underlying operating profit is stated before amortisation of intangibles.

 

Sales in the Enterprise Business for the year ended 31 March 2014 increased by 3 per cent., with underlying operating profit down £0.2 million to £1.1 million, largely driven by the end of some legacy support contracts and the changing product mix within the market. The new financial year has started in line with the financial year just ended.

 

Class 1 and Related Party Transaction

 

The Disposal is classified as a class 1 transaction under Chapter 10 of the Listing Rules.

 

Under Listing Rule 11.1.4, the Enterprise Management Team meets the definition of a related party because of the directorships of certain members of that team in the Company's subsidiary, AES Limited. As such, the Company is required to send a circular to its shareholders, in accordance with Listing Rule 13.3 and Listing Rule 13.6 and to obtain approval from shareholders for the Disposal, in addition to the requirements for a Class 1 transaction. The Enterprise Management Team will not vote on the resolution to be put to shareholders and will take all reasonable steps to ensure that none of their associates will vote on that resolution.

 

Details of the key individuals of the Enterprise Business are as follows:

Shaun Lynn

Managing Director and Director of AES Limited

Stephen Graham

Business Development Director

Steve Bailey

Service Director

Scott Lynn

Service Manager

John Street

Enterprise Operations Manager

Warren Playford

Enterprise Accounts Manager

 

 

 

Expected Timetable

 

The expected timetable for the principal events is set out below:

 

Circular to shareholders

 

Expected latest time and date for receipt of Forms of Proxy and

receipt of electronic proxy appointments via the CREST system

15 May 2014

 

 

11.00a.m. on 29 May 2014

 

Voting Record Time for General Meeting

 

29 May 2014

General Meeting

11.00a.m. on 2 June 2014

The General Meeting will be held at 2 Chancellor Court, Occam Road, Surrey Research Park, Guildford, Surrey, GU2 7AH.

 

 

Recommendation

 

The Board, having been so advised by Oriel Securities, considers the Disposal to be fair and reasonable so far as shareholders are concerned. The Board also considers that the Disposal is in the best interests of the Company and its shareholders as a whole and, therefore, recommends that shareholders vote in favour of the resolution to be proposed at the General Meeting, as each member of the Board who holds Ordinary Shares intends to do in respect of his or her own beneficial holdings of Ordinary Shares, such holdings comprising, in aggregate, 121,563 Ordinary Shares, representing approximately 0.39 per cent of the Company's existing issued share capital. In giving its advice, Oriel Securities has taken into account the commercial assessment of the Directors.

Notes

1. Shareholders should read the whole of the Circular to be sent to them and not just rely on the summarised information set out in this announcement.

2. Terms used in this announcement shall have the same meanings as set out in the Circular.

  

Notes to Editors:

 

About Acal plc

 

Acal is a European leader in specialist electronics, designing, manufacturing and distributing specialist electronic, photonic and medical products for the industrial and healthcare sectors. It is the only such provider with an infrastructure to deliver a broad range of specialist products and bespoke solutions across Europe. The Electronics division has completed seven acquisitions in the last four years, more than trebling its specialist revenues. Acal's strategy is to further enhance its leadership position through organic growth, complementary acquisitions and continued enhancement of its custom service capabilities. The division has operating companies across Europe including the UK, Germany, France, Benelux, Italy, Poland, Spain and the Nordic region as well as in Asia (China and South Korea) and Africa (South Africa). Businesses comprise Acal BFi, Hectronic, MTC, Myrra Group, RSG, Stortech and Vertec.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAAMITMBIBMBI
Date   Source Headline
18th Apr 20247:00 amRNSFull Year Trading Update
28th Mar 20247:30 amRNSDirector Declaration
22nd Mar 20248:09 amRNSNotification of Major Holdings
20th Mar 20243:45 pmRNSDirector/PDMR Shareholding
14th Mar 20241:21 pmRNSDirector/PDMR Shareholding
19th Feb 20244:07 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSTrading Update
29th Jan 202410:31 amRNSDirector / PDMR Shareholding
8th Jan 20248:41 amRNSNotification of Major Holdings
4th Jan 20244:03 pmRNSNotification of Major Holdings
21st Dec 20233:57 pmRNSNotification of Major Holdings
13th Dec 20239:03 amRNSNotification of Major Holdings
8th Dec 202310:52 amRNSNotification of Major Holdings
5th Dec 20237:00 amRNSInterim Results
22nd Nov 20238:30 amRNSNotice of Interim Results
11th Oct 20237:00 amRNSFirst Half Trading Update
15th Sep 20239:11 amRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSAcquisition of 2J Antennas Group
5th Sep 20232:17 pmRNSNotification of Major Holdings
31st Aug 20237:00 amRNSAcquisition completion - Silvertel
1st Aug 20237:00 amRNSAcquisition of Silvertel
24th Jul 20232:31 pmRNSResults of Annual General Meeting
24th Jul 20237:00 amRNSTrading Update
27th Jun 202310:53 amRNSDirector / PDMR Shareholding
27th Jun 202310:47 amRNSNotification of Major Holdings
22nd Jun 202312:35 pmRNSAnnual Report & Notice of AGM
19th Jun 20238:35 amRNSNotification of Major Holdings
15th Jun 20239:51 amRNSDirector LTIP Award
7th Jun 20237:00 amRNSPreliminary results
1st Jun 20232:50 pmRNSNotification of Major Holdings
30th May 20237:00 amRNSAppointment of Non-Executive Director
18th May 20231:33 pmRNSNotification of Major Holdings
17th May 202310:25 amRNSNotice of Full Year Results
19th Apr 20237:00 amRNSFull Year Trading Update
18th Apr 20237:00 amRNSNotification of Major Holdings
29th Mar 20235:47 pmRNSNotification of Major Holdings
15th Mar 20233:53 pmRNSNotification of Major Holdings
15th Mar 20238:37 amRNSNotification of Major Holdings
15th Mar 20237:00 amRNSNotification of Major Holdings
23rd Feb 20232:58 pmRNSNotification of Major Holdings
20th Feb 20239:48 amRNSNotification of Major Holdings
15th Feb 20235:33 pmRNSNotification of Major Holdings
13th Feb 202311:36 amRNSNotification of Major Holdings
25th Jan 20237:00 amRNSQ3 Trading Update and Acquisition Completion
6th Jan 20231:41 pmRNSNotification of Major Holdings
6th Jan 20238:24 amRNSNotification of Major Holdings
3rd Jan 202310:38 amRNSNotification of Major Holdings
22nd Dec 20227:00 amRNSAcquisition of Magnasphere Corporation
14th Dec 20224:31 pmEQSParadigm Biopharmaceuticals (PAR): Adapted therapies to meet unmet demand
5th Dec 20229:53 amEQSdiscoverIE Group (DSCV): Focused on sustainable growth

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.